VC  TriStar Technology Ventures

http://www.tstventures.com





     Office Locations:

3322 West End Ave., Suite 1110 11th Floor
Nashville, TN 37203
Phone: 615-515-9880
Fax: 615-515-9891

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    TriStar Technology Ventures is an early stage venture fund that focuses on forming and investing in companies in the area broadly defined as Healthcare Innovation: biotech, pharmaceuticals, personalized medicine, medical devices, healthcare IT and healthcare services. TriStar forms and invests in companies at the pre-seed/seed stage. Initial investments may range from $100,000 to $1,000,000, with a target total investment of between $1,000,000 to $2,000,000 over the life of the investment. TriStar's strategy has a specific focus on technologies and companies emerging from universities and research institutions. Once a business qualifies to receive investment funds, it may continue receiving funds so long as it continues to be headquartered and principally operated in Tennessee with at least 60% of its employees located in Tennessee. In 2012, the firm raised the TriStar Technology Fund II in order to expand investment opportunities beyond Tennessee.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Brian Laden Ph.D. Co-Founder and Managing Director
    Christopher Rand Co-Founder and Managing Director
    Harry R. Jacobson M.D. Co-Founder and Partner
    Lisa McWilliams Director of Investor Relations

     

    Portfolio companies include:


      BioStable
        web link


      Bjond
        web link


      Cerebrotech
        web link


      Cobra Stylet
        web link


      Device Innovation Group
        web link


      Diabetes Care Group
        web link


      Diagnovus


      GenomOncology
        web link


      Goba
        web link


      MedCenter Display
        web link


      Molecular Sensing
        web link


      OnFocus Healthcare


      Pathfinder
        web link


      TVA Medical
        web link


      VenX Medical
        web link


     

    Recent News: